Using [18F]FDG PET/CT to Identify Optimal Responders to Neoadjuvant Therapy in Breast Cancer—Results from a Prospective Patient CohortFabrizia Gelardi, Lidija Antunovic, Marcello Rodari et al.|Cancers|2025Cited by 3
Utility of [18F]FDG PET/CT in predicting pathological complete response to neoadjuvant therapy in breast cancer: A prospective study.Fabrizia Gelardi, Armando Santoro, Martina Sollini et al.|Journal of Clinical Oncology|2024Cited by 0